JASPI

SASPI Ltd. Systematic review/Scoping review with large effect size State-of-the-Art Review: Diagnosis and Management of Spinal Implant Infections DOI: 10.1093/cid/ciae436 Authors: Don Bambino Geno Tai et al.,   Highlights   Spinal implant infections are a serious complications of instrumented spinal fusion surgeries, carrying high morbidity and complex management challenges. Early postoperative infections may manifest with wound-healing […]

SASPI Ltd. Systematic review/Scoping review with large effect size The association between prenatal antibiotic exposure and adverse long-term health outcomes in children: a systematic review and meta-analysis DOI: 10.1016/j.jinf.2024.106377 Authors: Quynh A Duong et al.,   Highlight   1. Antibiotics are the most prescribed drugs during pregnancy. 2. Prenatal antibiotic exposure is associated with various immunological,

SASPI Ltd. RCTs having large positive / negative effect Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis The ADAPT-Sepsis Randomized Clinical Trial DOI: 10.1001/jama.2024.26458 Authors: world health Organization 2024   Abstract   Key Points: Question Do critically ill adult patients hospitalized for suspected sepsis and treated with intravenous antibiotics based on procalcitonin (PCT) or

SASPI Ltd. Technical document Global report on infection prevention and control 2024 DOI: 9789240103986 Authors: world health Organization 2024   Abstract Health care-associated infections (HAIs) affect patients and health systems every day, causing immense suffering, driving higher health-care costs and hampering efforts to achieve high-quality care for all. HAIs are often difficult to treat, are

SASPI Ltd. RCTs having large positive / negative effect, Other specific ASP article suggested by Editorial Board Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections DOI: 10.1056/NEJMoa2404991 Authors: The BALANCE Trial Investigators   Abstract Background: Bloodstream infections are associated with substantial morbidity and mortality. Early, appropriate antibiotic therapy is important, but the duration

SASPI Ltd. RCTs having large positive / negative effect Cost-effectiveness of faecal microbiota transplantation compared with vancomycin monotherapy for early Clostridioides difficile infection: economic evaluation alongside a randomised controlled trial DOI: 10.1016/j.jhin.2024.11.003 Authors: Camilla R. Birch et al.,   Abstract For Clostridioides difficile infection (CDI), faecal microbiota transplantation (FMT) is currently recommended for patients with three

SASPI Ltd. Guideline based on systematic review WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease Reference No:- https://www.who.int/publications/i/item/9789240100077 Guideline, WHO Abstract Rheumatic fever (RF) and Rheumatic heart disease (RHD) are a preventable public health problem in low- and middle-income countries and in marginalized communities in middle- and high-income countries.

SASPI Ltd. Multi-centric observational study with large effect Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: the PERCH study experience DOI: 10.1016/j.cmi.2024.10.023 Authors: Ryo Miyakawa et al.,   Abstract Objectives: After respiratory syncytial virus (RSV), human metapneumovirus (hMPV) was the second-ranked pathogen attributed to severe pneumonia in the PERCH

SASPI Ltd. Systematic review/Scoping review with large effect size Global landscape of vancomycin-resistant enterococci in hematopoietic stem-cell transplantation patients: a systematic review and meta-analysis DOI:- 10.1186/s12879-024-10100-0 Authors: Seyed Pooria Tadayon Nabavi et al.,   Abstract Background: One of the main risks of infection after hematopoietic stem cell transplantation (HSCT) is infection by gram-positive bacteria, including vancomycin-resistant enterococci

SASPI Ltd. ASPICON-2024 PGIMER Abstracts​ Dr Rahul Garg (Section editor), Abstract (1-83) authors. JASPI September 2024/ Volume 2/Issue 3 / Suppl. Issue Copyright: © Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.